A new University of Bristol-led project aims to ease pressure on the NHS by developing an artificial intelligence (AI) model to predict and reduce a patient’s risk of readmission to hospital.
A globally-renowned climate scientist has highlighted the need to better recognise and understand the many different adverse health effects posed by worsening climate change for current and future generations.
A new systematic review has found that a large number of cancer patients continue to undergo invasive surgeries in their final months of life, even though it is unclear whether they benefit from them. The research does not confirm whether patients are being overtreated. However, findings suggest that surgical treatment intensity is both high and costly for these patients.
The advancement of future cancer nanomedicines, like collective nanosystems, offers a chance to promote responsible governance by anticipating technological developments and addressing ethical issues. Collective nanosystems are large numbers of tiny nano-sized carriers that work together to find and remove cancer cells, drawing inspiration from teams of cooperative robots. Computer models and artificial intelligence can be used to enhance collective nanosystem design, aiming to accelerate targeted treatments and streamline drug development by reducing experimental time.
The results of a study into whether cancer detection dogs can smell bladder cancer in other dogs’ urine suggests that this could be an effective new way to diagnose the disease in dogs. The research, involving University of Bristol researchers, is published in Veterinary and Comparative Oncology.
"The Government needs a plan to fix our broken food system and turn the tide on the obesity public health emergency, says Lords committee.". This is the key conclusion reached by the House of Lords Food, Diet and Obesity Committee in a report published today. The report, ‘Recipe for health: a plan to fix our broken food system’, finds that obesity and diet-related disease are a public health emergency that costs society billions each year in healthcare costs and lost productivity.
A total of more than £5 million of funding has been awarded to three University of Bristol projects through the European Research Council (ERC) Consolidator Grants announced today (Tuesday 3 December 2024).
A new landmark report, led by the University of Bristol researchers, highlights that access to genomic testing for patients with a brain tumour, is inequitable: it is estimated that fewer than 5 per cent of eligible adult patients with a brain tumour are accessing certain tests.
A new report has revealed for the first time the wide-ranging and increasing health dangers posed by long-term weather extremes in the UK, as the effects of climate change deepen.
A study to find out the best ways of treating prostate cancer has been named the 2024 recipient of the Active Surveillance Patients International (ASPI) Special Award. The ProtecT trial, led by the Universities of Bristol and Oxford, received the award for game-changing research in the development of the active surveillance approach to managing low-risk prostate cancer. Their research has proved active monitoring in patients with lower-risk prostate cancer was as safe as aggressive treatments.
